Kristin VanderPas

Kristin VanderPas' practice focuses on public and private security offerings. She has represented both issuers and investment banks in a variety of equity and debt transactions, including initial public offerings, secondary offerings of common stock and convertible note offerings. Kristin is also a market leader in SPAC M&A transactions, representing both target companies and investors in the de-SPAC process in transactions ranging in value up to $5 billion. Kristin also counsels clients in general corporate and securities law matters.

Kristin’s representative transactions include advising:

• The underwriters in Guardant Health’s:
  • $237.5 million IPO
  • $367.4 million follow-on offering
  • $1.1 billion follow-on offering
  • $785.4 million follow-on offering
• The initial purchaser in Guardant Health’s offering of $1 billion aggregate principal amount of 0% convertible senior notes due 2027
• The underwriters in Health Catalyst’s:
  • $209.3 million IPO
  • $225 million follow-on offering
• The initial purchaser in Health Catalyst’s offering of $230 million aggregate principal amount of 2.25% convertible senior notes due 2025 with capped call
• The underwriters in Lulu’s Fashion Lounge’s $106 million IPO
• The underwriters in Expensify’s $302 million IPO
• The underwriters in Ventyx Biosciences 174.3 million IPO
• The underwriters in Cue Health’s $230 million IPO
• The underwriters in DiCE Therapeutics $234.6 million IPO
• The underwriters in Qualtrics’ $1.15 billion follow-on offering
• The underwriters in Opendoor Labs’ $886 million follow-on offering
• The underwriters in 10X Genomics’ $448.5 million IPO
• The underwriters in Livongo Health’s $408.5 million IPO
• Uber in its $8.1 billion IPO